SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,459,000 | +68.5% | 831,695 | +36.9% | 0.00% | +100.0% |
| Q1 2016 | $7,396,000 | -22.5% | 607,691 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $9,545,000 | +6.2% | 599,906 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $8,989,000 | -15.0% | 586,345 | +34.8% | 0.00% | 0.0% |
| Q2 2015 | $10,570,000 | +23.9% | 434,815 | +18.5% | 0.00% | +100.0% |
| Q1 2015 | $8,533,000 | +8.8% | 367,015 | +17.5% | 0.00% | 0.0% |
| Q4 2014 | $7,844,000 | +7.0% | 312,369 | +32.5% | 0.00% | 0.0% |
| Q3 2014 | $7,329,000 | +9.0% | 235,670 | -9.4% | 0.00% | 0.0% |
| Q2 2014 | $6,723,000 | +7.0% | 259,983 | -3.3% | 0.00% | 0.0% |
| Q1 2014 | $6,283,000 | +3.6% | 268,828 | +12.5% | 0.00% | 0.0% |
| Q4 2013 | $6,064,000 | +16.3% | 238,910 | -6.5% | 0.00% | 0.0% |
| Q3 2013 | $5,214,000 | +13.3% | 255,610 | +16.6% | 0.00% | 0.0% |
| Q2 2013 | $4,600,000 | – | 219,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |